- Report
- January 2022
- 60 Pages
Global
From €3501EUR$3,950USD£3,044GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4388EUR$4,950USD£3,814GBP
- Report
- February 2024
- 180 Pages
Global
From €4404EUR$4,969USD£3,829GBP
- Report
- August 2022
- 376 Pages
Global
From €2216EUR$2,500USD£1,926GBP
- Report
- November 2023
- 109 Pages
Global
From €3500EUR$4,230USD£3,149GBP
The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more